Baird lowered the firm’s price target on Genpact (G) to $50 from $56 and keeps a Neutral rating on the shares. The firm updated its model following Q1 results.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.